Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer-Reference-Cited by-同舟云学术

Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer

Published:2019-09 Issue:9 Volume:40 Page:913-919
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Davidson Tima,Amit Uri,Saad Akram,Hahiashvili Maia,Goshen Elinor,Portnoy Orith,Berger Raanan,Goldstein Adam,Sadetsky Igor,Weizman Noam,Chikman Bar,Dotan Zohar,Lawrence Yaacov R.,Ben-Haim Simona,Symon Zvi,Goldstein Jeff

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference41 articles.

1. Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016.;Carlaw;Prostate Int,2017

2. Imaging for prostate cancer recurrence.;Maurer;Eur Urol Focus,2016

3. 68Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature.;Zacho;Clin Physiol Funct Imaging,2018

4. Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)ga-PSMA-HBED-CC than with (18)F-fluoroethylcholine PET/CT.;Pfister;Eur J Nucl Med Mol Imaging,2016

5. PSMA-based detection of prostate cancer bone lesions with ¹8F-dcfpyl PET/CT: a sensitive alternative to (99m)tc-MDP bone scan and na¹8F PET/CT?;Rowe;Clin Genitourin Cancer,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2022-04-19

2. Inter-Observer Variability in the Interpretation of <sup>68</sup>Ga-PSMA PET-CT Scan according to PROMISE Criteria;Advances in Molecular Imaging;2022

3. Systematic review & meta-analysis of positron emission tomography/computed tomography and bone scan in the diagnosis of prostate lesions;Translational Andrology and Urology;2021-11

4. Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?;Nuclear Medicine Communications;2021-05-06

5. Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC);JCO Global Oncology;2021-04